Hiroki Yukami

1.7k total citations
20 papers, 152 citations indexed

About

Hiroki Yukami is a scholar working on Oncology, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, Hiroki Yukami has authored 20 papers receiving a total of 152 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 10 papers in Pathology and Forensic Medicine and 9 papers in Cancer Research. Recurrent topics in Hiroki Yukami's work include Genetic factors in colorectal cancer (10 papers), Cancer Genomics and Diagnostics (9 papers) and Colorectal Cancer Treatments and Studies (7 papers). Hiroki Yukami is often cited by papers focused on Genetic factors in colorectal cancer (10 papers), Cancer Genomics and Diagnostics (9 papers) and Colorectal Cancer Treatments and Studies (7 papers). Hiroki Yukami collaborates with scholars based in Japan, United States and Taiwan. Hiroki Yukami's co-authors include Daisuke Kotani, Yoshiaki Nakamura, Takayuki Yoshino, Takeshi Kato, Hiroya Taniguchi, Eiji Oki, Saori Mishima, Ichiro Takemasa, Alexey Aleshin and Hiromichi Shirasu and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Cancer Science.

In The Last Decade

Hiroki Yukami

16 papers receiving 152 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hiroki Yukami Japan	6	104	92	85	51	24	20	152
Daniela Dinu Romania	7	43 0.4×	101 1.1×	77 0.9×	37 0.7×	68 2.8×	15	191
Emerik Österlund Sweden	5	64 0.6×	103 1.1×	46 0.5×	32 0.6×	26 1.1×	14	146
Daniele Rizzi Italy	5	90 0.9×	136 1.5×	59 0.7×	95 1.9×	18 0.8×	15	184
E. Ococks United Kingdom	3	84 0.8×	76 0.8×	40 0.5×	82 1.6×	54 2.3×	3	198
Iris van ’t Erve Netherlands	6	99 1.0×	78 0.8×	66 0.8×	45 0.9×	25 1.0×	12	143
Cosimo Rasola Italy	7	37 0.4×	88 1.0×	48 0.6×	26 0.5×	13 0.5×	16	118
Joan Bratton United States	4	94 0.9×	91 1.0×	50 0.6×	28 0.5×	10 0.4×	6	168
Kathleen L.J. Daenen Netherlands	3	56 0.5×	124 1.3×	118 1.4×	68 1.3×	130 5.4×	3	241
Ilaria Depetris Italy	7	38 0.4×	119 1.3×	61 0.7×	42 0.8×	45 1.9×	10	194
Lisa Miller‐Phillips Germany	5	52 0.5×	189 2.1×	76 0.9×	67 1.3×	45 1.9×	8	215

Countries citing papers authored by Hiroki Yukami

Since Specialization

Citations

This map shows the geographic impact of Hiroki Yukami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroki Yukami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroki Yukami more than expected).

Fields of papers citing papers by Hiroki Yukami

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroki Yukami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroki Yukami. The network helps show where Hiroki Yukami may publish in the future.

Co-authorship network of co-authors of Hiroki Yukami

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroki Yukami. A scholar is included among the top collaborators of Hiroki Yukami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroki Yukami. Hiroki Yukami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kodama, Hiroyuki, et al.. (2025). Chemotherapy Efficacy in Patients With Colorectal Cancer Experiencing Early Recurrence During or After Adjuvant Chemotherapy. Anticancer Research. 45(4). 1695–1705.

Kawabata, Ryohei, Daisuke Sakai, Toshio Shimokawa, et al.. (2025). Efficacy and safety of irinotecan-based therapy in elderly patients with advanced gastric cancer receiving third-line or later chemotherapy: post-hoc age-subgroup analysis of the rindberg trial. Gastric Cancer. 29(1). 220–229.

Kodama, Hiroyuki, et al.. (2025). A Case of Possible Infusion-Related Reactions Caused by Palonosetron. Case Reports in Oncology. 18(1). 353–360. 1 indexed citations

Yukami, Hiroki, Shunji Endo, Shogen Boku, et al.. (2025). ASTRON (OGSG 2401) study protocol: Ferric carboxymaltose for iron deficiency anemia in gastrointestinal cancer. Future Oncology. 21(26). 3395–3400.

Yukami, Hiroki, Yoshiaki Nakamura, Saori Mishima, et al.. (2024). Circulating tumor DNA (ctDNA) dynamics in patients with colorectal cancer (CRC) with molecular residual disease: Updated analysis from GALAXY study in the CIRCULATE-JAPAN.. Journal of Clinical Oncology. 42(3_suppl). 6–6. 11 indexed citations

Miyo, Masaaki, Takeshi Kato, Yoshiaki Nakamura, et al.. (2024). Association of circulating tumor DNA (ctDNA) molecular disease (MRD) detection with lymph node metastasis after local excision of pathological T1 colorectal cancer: First results from DENEB, a CIRCULATE-Japan GALAXY substudy.. Journal of Clinical Oncology. 42(3_suppl). 23–23.

Nakamura, Yoshiaki, Daisuke Kotani, Hiroki Yukami, et al.. (2023). 558MO Circulating tumor (ct)DNA as a prognostic biomarker in patients (pts) with resected colorectal cancer (CRC): An updated 24 months (mos) disease free survival (DFS) analysis from GALAXY study (CIRCULATE-Japan). Annals of Oncology. 34. S415–S416. 3 indexed citations

Oki, Eiji, Daisuke Kotani, Yoshiaki Nakamura, et al.. (2023). Circulating tumor DNA dynamics as an early predictor of recurrence in patients with radically resected colorectal cancer: Updated results from GALAXY study in the CIRCULATE-Japan.. Journal of Clinical Oncology. 41(16_suppl). 3521–3521. 6 indexed citations

Oki, Eiji, Daisuke Kotani, Yoshiaki Nakamura, et al.. (2023). Postoperative circulating tumor DNA-based molecular residual disease in patients with BRAF V600E and MSI-H colorectal cancer: Updated results from GALAXY study in the CIRCULATE-Japan.. JCO Global Oncology. 9(Supplement_1). 32–32. 1 indexed citations

10.

Sawada, Kentaro, Daisuke Kotani, Hiroki Yukami, et al.. (2022). Definitive chemoradiotherapy has comparable survival outcomes to esophagectomy in patients with clinical T1N0M0 esophageal squamous cell carcinoma: real-world data. International Journal of Clinical Oncology. 27(8). 1279–1288. 2 indexed citations

11.

Taniguchi, Hiroya, Yoshiaki Nakamura, Daisuke Kotani, et al.. (2021). CIRCULATE‐Japan: Circulating tumor DNA–guided adaptive platform trials to refine adjuvant therapy for colorectal cancer. Cancer Science. 112(7). 2915–2920. 92 indexed citations

12.

Kodama, Hiroyuki, Tetsuji Terazawa, Hiroki Yukami, et al.. (2021). Retrospective Comparison of mFOLFOXIRI With XELOX/SOX as Neoadjuvant Chemotherapy for Locally Advanced Rectal Cancer. In Vivo. 35(2). 977–985. 3 indexed citations

13.

Kadota, Tomohiro, Atsushi Inaba, Hiroki Yukami, et al.. (2021). Long-term clinical outcomes of patients diagnosed with pT1a-muscularis mucosae with lymphovascular invasion or pT1b after endoscopic resection for cT1N0M0 esophageal squamous cell carcinoma. Esophagus. 19(1). 153–162. 6 indexed citations

14.

Yukami, Hiroki, Yoshiaki Nakamura, Jun Watanabe, et al.. (2021). Minimal residual disease by circulating tumor DNA analysis for colorectal cancer patients receiving radical surgery: An initial report from CIRCULATE-Japan.. Journal of Clinical Oncology. 39(15_suppl). 3608–3608. 4 indexed citations

15.

Yukami, Hiroki, Saori Mishima, Daisuke Kotani, et al.. (2020). P-120 Prospective observational study monitoring circulating tumor DNA in resectable colorectal cancer patients undergoing radical surgery: GALAXY study in CIRCULATE-Japan (trial in progress). Annals of Oncology. 31. S128–S129. 7 indexed citations

16.

Yukami, Hiroki, Daisuke Kotani, Eiji Oki, et al.. (2020). 113TiP Prospective observational study monitoring circulating tumour DNA in resectable colorectal cancer patients undergoing radical surgery: GALAXY study in CIRCULATE-Japan. Annals of Oncology. 31. S1285–S1286. 2 indexed citations

17.

Kodama, H., Takanori Yamaguchi, Naoki Ishizuka, et al.. (2020). SO-17 Association between tumor budding grade and T stage as prognostic value for recurrence with high-risk stage II colon cancer: A retrospective study. Annals of Oncology. 31. S223–S223. 1 indexed citations

18.

Nakamura, Yoshiaki, Akinori Sasaki, Hiroki Yukami, et al.. (2020). Emergence of Concurrent MultipleEGFRMutations andMETAmplification in a Patient WithEGFR-Amplified Advanced Gastric Cancer Treated With Cetuximab. JCO Precision Oncology. 4(4). 1407–1413. 9 indexed citations

19.

Yukami, Hiroki, et al.. (2018). Impact of modified FOLFOX‐6 for patients with gastric cancer and a gastrointestinal obstruction. Asia-Pacific Journal of Clinical Oncology. 15(5). e91–e96. 3 indexed citations

20.

Yukami, Hiroki, Tetsuji Terazawa, Takahiro Miyamoto, et al.. (2017). The efficacy of aprepitant for the patients receiving FOLFOXIRI and FOLFIRINOX: A phase II study.. Journal of Clinical Oncology. 35(4_suppl). 560–560. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact